Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oxidized LDL contains inflammatory PAF-like phospholipids.

G K Marathe1, S M Prescott, G A Zimmerman

  • 1Department of Pathology, University of Utah, Salt Lake City, Utah, USA.

Trends in Cardiovascular Medicine
|November 1, 2001
PubMed
Summary

Oxidized low-density lipoprotein (LDL) contains platelet-activating factor (PAF) mimetics that promote atherosclerosis. These uncontrolled inflammatory agents are found in lesions and blood, contributing to the disease process.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retinoic acid receptor-α regulates synthetic events in human platelets.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Combined variants in factor VIII and prostaglandin synthase-1 amplify hemorrhage severity across three generations of descendants.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Non-genomic activities of retinoic acid receptor alpha control actin cytoskeletal events in human platelets.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases.

Journal of thrombosis and haemostasis : JTH·2013
Same author

The septic milieu triggers expression of spliced tissue factor mRNA in human platelets.

Journal of thrombosis and haemostasis : JTH·2011
Same author

Cardiovascular effects of platelet-activating factor.

Trends in cardiovascular medicine·2011

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiovascular Science

Background:

  • Atherosclerosis involves inflammation, with oxidized low-density lipoprotein (LDL) playing a key role in its progression.
  • Oxidized LDL supplies cholesterol and generates inflammatory agents that activate key cells like macrophages and endothelial cells.

Purpose of the Study:

  • To describe the structure, activity, and metabolism of platelet-activating factor (PAF)-like lipids found in atherogenic LDL particles.
  • To investigate the role of phospholipid oxidation products in the inflammatory processes of atherosclerosis.

Main Methods:

  • Analysis of oxidized low-density lipoprotein (LDL) particles.
  • Characterization of phospholipid oxidation products and their structural mimicry of platelet-activating factor (PAF).

Related Experiment Videos

  • Assessment of the activity of PAF mimetics on relevant cellular targets.

    • Main Results:

    • Specific phospholipid oxidation products in LDL mimic the potent inflammatory mediator platelet-activating factor (PAF).
    • These PAF mimetics activate the PAF receptor on platelets, monocytes, and leukocytes.
    • Uncontrolled production of these PAF mimetics occurs, unlike the regulated physiological generation of PAF.
    • PAF mimetics and other oxidized phospholipids are detected in atherosclerotic lesions and blood.

    Conclusions:

    • Oxidized LDL contains uncontrolled inflammatory agents, PAF mimetics, that contribute to atherogenesis.
    • These PAF-like lipids are implicated in the inflammatory cascade of atherosclerosis.
    • Understanding these lipids is crucial for developing therapeutic strategies against atherosclerosis.